Ikänik Farms Triggers $30 Million Self-Directed, Non-Brokered Private Placement with European Private Equity Group prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Ikänik Farms Registers and Commercializes 6 CBD Products Eligible for Sale in Colombia, Ecuador, Bolivia & Peru
News provided by
Share this article
Company or
Ikänik Farms ) is pleased to announce that its wholly owned, Colombian subsidiary Pideka SAS (
Pideka ), has completed the registration and commercialization process of six cannabis-based cosmetic products through the National Institute of Drug and Food Surveillance (INVIMA), the governing body in Colombia responsible new product registrations. We are excited to open the door to multiple countries concurrent with our product registrations and look forward to better serving the Latin American markets in the near future. said Brian Baca, CEO of Ikänik Farms.
/PRNewswire/ THC is perhaps the most well-known cannabinoid within cannabis. THC, short for tetrahydrocannabinol, is famously responsible for cannabis s.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Ikänik Farms to Commence Trading on German Börse-Frankfurt Exchange
April 21, 2021 GMT
Ikanik Farms Inc. (CNW Group/Ikanik Farms Inc.)
CORONA, Calif., April 21, 2021 /PRNewswire/ - Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) (the “Company” or “Ikänik”) is pleased to announce the Company has received approval from the Börse-Frankfurt Exchange (the “Börse-Frankfurt”) for its subordinate voting shares to commence trading under the symbol “DFMA”, beginning April 21, 2021.
“We are excited to expand our exchange offering into the European market, providing broader access for our investor base.” said Brian Baca, CEO of Ikänik Farms.
Ikänik Farms Registers and Commercializes 16 Additional Cultivares From its Colombian Phytosanitary Seed Bank
News provided by
Share this article
Company or
Ikänik Farms ) is pleased to announce that its wholly owned, Colombian subsidiary Pideka SAS (
Pideka ), has completed the registration and commercialization process, introducing 16 new cultivars for commercial sale, many of which have a THC content over 20%. The new strains will be eligible for sale immediately and will be added to its production quota recently issued from the Colombian government to produce psychoactive cannabis for the 2021, fiscal year. We are excited to broaden our cultivar base offering, and provide options to national and international clients, interested in psychoactive and non-psychoactive material from the Colombian market, with California led quality. said Brian Baca, CEO of Ikänik Farms.